Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
440
-
Total 13F shares, excl. options
-
53.8M
-
Shares change
-
+417K
-
Total reported value, excl. options
-
$9.05B
-
Value change
-
+$70.2M
-
Put/Call ratio
-
0.55
-
Number of buys
-
201
-
Number of sells
-
-200
-
Price
-
$168.36
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q1 2023
499 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q1 2023.
REPLIGEN CORP - COMMON STOCK (RGEN) has 440 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.8M shares
of 56.2M outstanding shares and own 95.63% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.27M shares), VANGUARD GROUP INC (5.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.76M shares), FMR LLC (2.02M shares), STATE STREET CORP (1.64M shares), SANDS CAPITAL MANAGEMENT, LLC (1.61M shares), WELLINGTON MANAGEMENT GROUP LLP (1.49M shares), BROWN CAPITAL MANAGEMENT LLC (1.44M shares), Invesco Ltd. (1.39M shares), and Artisan Partners Limited Partnership (1.22M shares).
This table shows the top 440 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.